Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account

被引：6

作者：

Gonzalez-Rodriguez, Elena ^{[1
]}

Aubry-Rozier, Berengere ^{[1
]}

Stoll, Delphine ^{[1
]}

Zaman, Khalil ^{[2
]}

Lamy, Olivier ^{[1
,3
]}

机构：

[1] Univ Lausanne, Univ Lausanne Hosp, Ctr Bone Dis, Lausanne, Switzerland

[2] Univ Lausanne, Univ Lausanne Hosp, Breast Ctr, Lausanne, Switzerland

[3] Univ Lausanne, Univ Lausanne Hosp, Serv Internal Med, Lausanne, Switzerland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 14期

关键词：

BREAST-CANCER;

D O I：

10.1200/JCO.19.02678

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1641 / +

页数：3

共 11 条

[1] Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases [J].

Anastasilakis, Athanasios D. ;

Polyzos, Stergios A. ;

Makras, Polyzois ;

Aubry-Rozier, Berengere ;

Kaouri, Stella ;

Lamy, Olivier .

JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (06) :1291-1296

[2]

[Anonymous], 2018, J CLIN ONCOL S

[3] Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports [J].

Aubry-Rozier, B. ;

Gonzalez-Rodriguez, E. ;

Stoll, D. ;

Lamy, O. .

OSTEOPOROSIS INTERNATIONAL, 2016, 27 (05) :1923-1925

[4] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass [J].

Bone, Henry G. ;

Bolognese, Michael A. ;

Yuen, Chui Kin ;

Kendler, David L. ;

Miller, Paul D. ;

Yang, Yu-Ching ;

Grazette, Luanda ;

San Martin, Javier ;

Gallagher, J. Christopher .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :972-980

[5] Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension [J].

Cummings, Steven R. ;

Ferrari, Serge ;

Eastell, Richard ;

Gilchrist, Nigel ;

Jensen, Jens-Erik Beck ;

McClung, Michael ;

Roux, Christian ;

Torring, Ove ;

Valter, Ivo ;

Wang, Andrea T. ;

Brown, Jacques P. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (02) :190-198

[6] Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial [J].

Gnant, Michael ;

Pfeiler, Georg ;

Dubsky, Peter C. ;

Hubalek, Michael ;

Greil, Richard ;

Jakesz, Raimund ;

Wette, Viktor ;

Balic, Marija ;

Haslbauer, Ferdinand ;

Melbinger, Elisabeth ;

Bjelic-Radisic, Vesna ;

Artner-Matuschek, Silvia ;

Fitzal, Florian ;

Marth, Christian ;

Sevelda, Paul ;

Mlineritsch, Brigitte ;

Steger, Guenther G. ;

Manfreda, Diether ;

Exner, Ruth ;

Egle, Daniel ;

Bergh, Jonas ;

Kainberger, Franz ;

Talbot, Susan ;

Warner, Douglas ;

Fesl, Christian ;

Singer, Christian F. .

LANCET, 2015, 386 (9992) :433-443

[7] Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors [J].

Gonzalez-Rodriguez, Elena ;

Aubry-Rozier, Berengere ;

Stoll, Delphine ;

Zaman, Khalil ;

Lamy, Olivier .

BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) :153-159

[8] Stopping Denosumab [J].

Lamy, Olivier ;

Stoll, Delphine ;

Aubry-Rozier, Berengere ;

Rodriguez, Elena Gonzalez .

CURRENT OSTEOPOROSIS REPORTS, 2019, 17 (01) :8-15

[9] Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline [J].

Shapiro, Charles L. ;

Van Poznak, Catherine ;

Lacchetti, Christina ;

Kirshner, Jeffrey ;

Eastell, Richard ;

Gagel, Robert ;

Smith, Sean ;

Edwards, Beatrice J. ;

Frank, Elizabeth ;

Lyman, Gary H. ;

Smith, Matthew R. ;

Mhaskar, Rahul ;

Henderson, Tara ;

Neuner, Joan .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) :2916-+

[10]

US Food and Drug Administration, HIGHL PRESCR DAT

← 1 2 →